These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10587578)

  • 1. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study.
    Lambert JC; Brousseau T; Defosse V; Evans A; Arveiler D; Ruidavets JB; Haas B; Cambou JP; Luc G; Ducimetière P; Cambien F; Chartier-Harlin MC; Amouyel P
    Hum Mol Genet; 2000 Jan; 9(1):57-61. PubMed ID: 10587578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
    Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.
    Laws SM; Hone E; Gandy S; Martins RN
    J Neurochem; 2003 Mar; 84(6):1215-36. PubMed ID: 12614323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
    Halimi G; Duplan L; Bideau C; Iniesta D; Berthézène P; Oddoze C; Verdier JM; Michel B; Bergé-Lefranc JL
    Neuroreport; 2000 Nov; 11(16):3599-601. PubMed ID: 11095526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the apolipoprotein E gene regulatory region in relation to coronary heart disease and their effect on plasma apolipoprotein E.
    Corbo RM; Scacchi R; Vilardo T; Ruggeri M
    Clin Chem Lab Med; 2001 Jan; 39(1):2-6. PubMed ID: 11256794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
    Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
    Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset.
    Beyer K; Lao JI; Gómez M; Riutort N; Latorre P; Mate JL; Ariza A
    Neurosci Lett; 2002 Jul; 326(3):187-90. PubMed ID: 12095653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction.
    Xu H; Li H; Liu J; Zhu D; Wang Z; Chen A; Zhao Q
    PLoS One; 2014; 9(8):e104608. PubMed ID: 25111308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the association between Apolipoprotein E polymorphism and risks of myocardial infarction.
    Shao A; Shi J; Liang Z; Pan L; Zhu W; Liu S; Xu J; Guo Y; Cheng Y; Qiao Y
    BMC Cardiovasc Disord; 2022 Mar; 22(1):126. PubMed ID: 35331149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations.
    Viiri LE; Loimaala A; Nenonen A; Islam S; Vuori I; Karhunen PJ; Lehtimäki T
    Atherosclerosis; 2005 Mar; 179(1):161-7. PubMed ID: 15721023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease.
    Kolovou G; Yiannakouris N; Hatzivassiliou M; Malakos J; Daskalova D; Hatzigeorgiou G; Cariolou MA; Cokkinos DV
    Curr Med Res Opin; 2002; 18(3):118-24. PubMed ID: 12094820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
    Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
    Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
    Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
    Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease.
    Al-Meghaiseeb ES; Al-Otaibi MM; Al-Robayan A; Al-Amro R; Al-Malki AS; Arfin M; Al-Asmari AK
    World J Gastroenterol; 2015 Jan; 21(3):897-904. PubMed ID: 25624723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.